ArticleBMC cardiovascular disorders2026
Clinical manifestations, predictors, early markers and potential mechanisms associated with low cardiac output syndrome after cardiac valve replacement.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTo identify the clinical manifestations, predictors, early markers and potential pathophysiological mechanisms associated with the development of low cardiac output syndrome (LCOS) after cardiac valve replacement (CVR) surgery.
methodsA retrospective analysis of prospectively collected data from the hospital's clinical research database. Between February 2020 and April 2024, 105 patients who underwent CVR were included based on diagnostic criteria and data integrity. Stepwise logistic regression was used to identify independent predictors and early markers for LCOS and prolonged hospital stay.
resultsThe overall prevalence of LCOS was 28%. Multivariate regression analysis identified the predictors for LCOS as a lower preoperative ejection fraction (OR: 0.917), and early markers as a immediate postoperative higher lymphocyte count (OR: 7.462) and a lower hematocrit (OR: 0.88). Additionally, lower hemoglobin concentration (B: -0.038, P = 0.004) and reduced high-density lipoprotein (HDL) level (B: -1.573, P = 0.039) were each independently associated with increased risk of LCOS. Conversely, elevated C-reactive protein (CRP) (B: 0.011, P = 0.01) and lactate dehydrogenase (LDH) concentrations (B: 0.002, P = 0.046) were independently associated with higher LCOS incidence. Patients with LCOS exhibited significantly longer duration of hospitalization compared to those without LCOS (34.2 versus 24.8 days, P < 0.01). Furthermore, LCOS patients were characterized by older age, higher utilization of positive inotropic drugs, significantly lower HDL levels (0.9 versus 1.0 mmol/L, P = 0.036), and markedly elevated CRP concentrations (79.1 versus 44.4 mg/L, P = 0.012).
conclusionsLCOS is significantly associated with increased morbidity and prolonged hospitalization. Strategies such as inhibiting systemic inflammation, optimizing hemorheological parameters, and preserving cardiac function may potentially reduce the incidence of LCOS, thereby improving postoperative outcomes after CVR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.